Дуже хороша людина. Талановитий лікар від Бога! Дякую Вам Василь Миколайович!!!
Clinic's answer: Щиро дякуємо, Людмило, за Ваш відгук!
Shpilka Vasyl Mykolaiovych| Code | Name | Price | Days | Book |
|---|---|---|---|---|
| HORMONAL PANEL | ||||
| Thyroid panel | ||||
| 101 | Thyrotropic hormone | 290 | 1 | |
| 103 | Free triiodothyronine (T3 free) | 290 | 1 | |
| 105 | Free thyroxin (T4 free) | 290 | 1 | |
| 106 | Thyroglobulin | 330 | 1 | |
| 107 | Thyroglobulin Antibodies | 340 | 1 | |
| 108 | Thyroperoxidase antibodies | 380 | 1 | |
| 215 | Antibodies to receptors | 720 | Up to 5 | |
| 502 | Calcitonin | 575 | Up to 5 | |
| 2001 | Package №1 «Thyroid-General » Free Thyroid (T3 free)Thyroxine free (T4 free) | 870 | 1 | |
| 2002 | Package №2 «Thyroid-autoimmune » Antibodies to thyroid peroxidase Antibodies to thyroglobulin, Thyroglobulin | 1055 | 1 | |
| 2003 | Package №3 «Thyroid-autoimmune » Antibodies to thyroid peroxidase Antibodies to thyroglobulin, Thyroglobulin (ТГ) Carcinoembryonal antigen ( CEA) (РЕА) | 1065 | 1 | |
| 2004 | Package №4 «Thyroid-screening » , Thyroxine free (T4 free), Antibodies to thyroperoxidase | 960 | 1 | |
| 2034 | Package №34 «Thyroid-1 » , Thyroxine free (T4 free), Free thryroxin (T3 free) Antibodies to thyroperoxidase | 1250 | 1 | |
| 2038 | Package №38 «Thyroid-1 » , Thyroxine free (T4 free), Antibodies to therioglobulin | 920 | 1 | |
| Reproductive panel | ||||
| 110 | Luteinizing hormone (LH) | 340 | 1 | |
| 111 | Follicle stimulating hormone (FSH) | 320 | 1 | |
| 112 | Prolactin | 330 | 1 | |
| 1222 | Prolactin fractions | 650 | ||
| 113 | Progesterone | 310 | 1 | |
| 114 | Testosterone general | 320 | 1 | |
| 115 | Testosterone free | 400 | from 1 to 3 | |
| 116 | Estradiol (E2) | 310 | 1 | |
| 117 | Sex-binding globulin (SHBG) | 340 | from 1 to 3 | |
| 119 | Anti-Mullerian hormone (AMH MIS) | 790 | Up to 5 | |
| 126 | Androstenedione | 510 | up to 5 | |
| 127 | Dihydrotestosterone (DHT) | 545 | up to 5 | |
| 2007 | Package №7 “Reproduction of the first phase” Luteinizing hormone (LH), Follicle-stimulating hormone (FSH), Prolactin, Estradiol (E2) | 1300 | 1 | |
| 2008 | Package № 8 «Reproduction of the second phase » Luteinizing hormone (LH), Follicle-stimulating hormone (FSH), Prolactin, Progesterone | 1300 | 1 | |
| 2009 | Package № 9 «Reproduction - 1 » Prolactin, Progesterone, Testosterone total, sex hormone binding globulin (CCO), Free androgen Index | 1300 | from 1 to 3 | |
| 2010 | Package № 10 «Reproduction - 2 » Luteinizing hormone (LH), Follicle-stimulating hormone (FSH), Prolactin, Progesterone, Estradiol (E2), Sex-binding globulin (SBG), General testosterone, Free androgen index | 2270 | 1 | |
| 2011 | Package No. 11 “Free androgen index” Sex hormone-binding globulin (SHBG), Total testosterone, Free androgen index | 660 | 1 | |
| 2035 | Package No. 35 “Reproduction– 3” Luteinizing hormone (LH), Follicle-stimulating hormone (FSH), Prolactin | 990 | 1 | |
| 2042 | Package No. 42 “Hyperprolactinemia” Thyroid-stimulating hormone (TSH), Free thyroxine (T4 free), Prolactin | 910 | 1 | |
| 2059 | Package No. 59 “Hyperandrogenism” Total testosterone, 17-alpha-hydroxyprogesterone (17-a-ONP), Dehydroepiandrosterone sulfate (DHEA-S), Sex hormone-binding globulin (SHBG), Free androgen index. | 1425 | up to 3 | |
| Prenatal diagnostics | ||||
| 120 | Alpha-fetoprotein (AFP) (14-19 weeks of pregnancy) | 360 | 1 | |
| 121 | PAPP-A (Pregnancy-associated plasma protein-A (8-14 weeks of pregnancy) | 340 | 1 | |
| 122 | Free β-hCG (11-14 weeks of pregnancy) | 340 | 1 | |
| 124 | Chorionic gonadotropin – prenatal diagnosis | 350 | 1 | |
| Pituitary-adrenal markers | ||||
| 938 | 17-OH-Progesterone | 400 | up to 3 | |
| 118 | Dehydroepiandrosterone sulfate (DHEA-SO4) | 365 | 1 | |
| 459 | Cortisol | 450 | up to 3 | |
| ONCOLOGICAL PANEL | ||||
| 132 | Breast cancer marker (CA 15-3) | 370 | 1 | |
| 133 | Ovarian tumor marker (CA-125) | 350 | 1 | |
| 135 | Carcinoembryonic antigen (CEA, CEA) | 350 | 1 | |
| 136 | Free prostate-specific antigen (FPSA) | 370 | 1 | |
| 137 | Total prostate-specific antigen (T PSA) | 350 | 1 | |
| 138 | Alpha-fetoprotein (AFP) | 360 | 1 | |
| 139 | Chorionic gonadotropin | 350 | 1 | |
| 723 | Early ovarian cancer marker HE4 | 880 | up to 3 | |
| 2014 | Package No. 14 «PSA» Total prostate-specific antigen (T PSA), Free prostate-specific antigen (FPSA), Ratio of free PSA to total PSA | 720 | 1 | |
| 2015 | Package No. 15 «Women's oncological» Thyroglobulin (TG), Breast cancer marker (CA 15-3), Ovarian cancer marker (CA 125), Carcinoembryonic antigen (CEA) | 1400 | 1 | |
| 2031 | Package No. 31 “Laboratory diagnosis of ovarian cancer” Early ovarian tumor marker (HE-4), ovarian tumor marker (CA-125), ROMA index | 1100 | up to 3 | |
| INFECTIOUS PANEL | ||||
| Hepatitis | ||||
| 912 | Hepatitis B virus (HBV), HBsAg (Australian antigen) | 500 | 1 | |
| 916 | Hepatitis B virus (HBV), HBcAg, total antibodies | 500 | 1 | |
| 919 | Hepatitis C virus (HCV), total antibodies | 500 | 1 | |
| 2045 | Package No. 45 «Hepatitis» Hepatitis A virus IgM antibodies, Hepatitis B virus HBsAg (Australia antigen), Hepatitis B virus HBcAg total antibodies, Hepatitis C virus total antibodies | 1500 | 1 | |
| 2046 | Package No. 46 "Hepatitis B, primary screening" HBsAg (Australian antigen), total HBcAg antibodies | 1000 | 1 | |
| TORCH infections | ||||
| 141 | Cytomegalovirus (CMV), IgM antibodies | 370 | 1 | |
| 142 | Cytomegalovirus (CMV), IgG antibodies | 370 | 1 | |
| 144 | Herpes simplex virus type 2 (HSV), IgG antibodies | 370 | 1 | |
| 931 | Herpes simplex virus 1/2 type (HSV), IgG antibodies | 370 | 1 | |
| 143 | Herpes virus type ½ (HSV), IgM antibodies | 370 | 1 | |
| 145 | Rubella virus, IgM antibodies | 370 | 1 | |
| 146 | Rubella virus, IgG antibodies | 370 | 1 | |
| 147 | Toxoplasma, IgM antibodies | 370 | 1 | |
| 148 | Toxoplasma, IgG antibodies | 370 | 1 | |
| 2017 | Package No. 17 "TORCH IgG" before pregnancy; Cytomegalovirus IgG antibodies, Herpes simplex virus type 1/2 IgG antibodies, Toxoplasma IgG antibodies, Rubella virus IgG antibodies | 1480 | 1 | |
| 2018 | Package No. 18 "TORCH IgG without rubella" before pregnancy; Cytomegalovirus antibodies IgG, Herpes simplex virus type 1/2 antibodies IgG, Toxoplasma antibodies IgG | 1110 | 1 | |
| 2019 | Package No. 19 "TORCH IgG with chlamydia without rubella" before pregnancy; Cytomegalovirus antibodies IgG, Herpes simplex virus type 1/2 antibodies IgG, Toxoplasma antibodies IgG, Chlamydia antibodies IgG | 1480 | 1 | |
| 2020 | Package No. 20 "TORCH IgG" Cytomegalovirus antibodies IgG, Toxoplasma antibodies IgG, Rubella virus antibodies IgG | 1100 | 1 | |
| 2021 | Package No. 21 "TORCH IgM" during pregnancy; Cytomegalovirus antibodies IgM, Toxoplasma antibodies IgM, Rubella virus antibodies IgM | 1100 | 1 | |
| 2022 | Package No. 22 "TORCH IgG, IgM with herpes" Cytomegalovirus antibodies IgG and IgM, Toxoplasma antibodies IgG and IgM, Rubella virus antibodies IgG and IgM, Herpes simplex virus type 1/2 antibodies IgG and IgM | 2960 | 1 | |
| 2023 | Package No. 23 "TORCH IgG, IgM" Cytomegalovirus antibodies IgG and IgM, Toxoplasma antibodies IgG and IgM, Rubella virus antibodies IgG and IgM | 2220 | 1 | |
| 2030 | Package No. 30 “Infectious” Cytomegalovirus antibodies IgG, Herpes simplex virus type 1/2 antibodies IgG, Toxoplasma antibodies IgG, Epstein-Barr virus (nuclear antigen) antibodies IgG | 1480 | 1 | |
| Airborne droplet infections | ||||
| 308 | Measles virus IgM antibodies | 950 | up to 5 | |
| 309 | IgG antibodies to measles virus (Measles virus IgG) | 550 | up to 5 | |
| Urogenital infections | ||||
| 151 | Chlamydia, IgG antibodies | 370 | 1-2 | |
| 157 | Chlamydia, IgM antibodies | 370 | 1-2 | |
| 153 | Mycoplasma hominis, IgG antibodies | 370 | 1-2 | |
| 155 | Ureaplasma urealyticum, IgG antibodies | 370 | 1-2 | |
| 2024 | Package No.24 Urogenital" Chlamydia IgG antibodies, Ureaplasma urealyticum IgG antibodies, Mycoplasma hominis IgG antibodies | 1110 | 1-2 | |
| Gastroenterological infections | ||||
| 161 | Helicobacter pylori, IgG antibodies | 360 | 1 | |
| 200 | Helicobacter pylori, stool antigen | 500 | 1 | |
| Diagnosis of infectious mononucleosis | ||||
| 162 | Epstein-Barr virus (nuclear antigen), IgG antibodies | 360 | 1 | |
| 163 | IgG class antibodies to Epstein-Barr virus early antigen | 500 | up to 5 | |
| 164 | IgG class antibodies to Epstein-Barr virus capsid antigen | 360 | up to 3 | |
| 940 | IgM class antibodies to Epstein-Barr virus capsid antigen | 450 | up to 3 | |
| 527 | Epstein-Barr virus, Real-Time PCR, with quantitative determination if detected (saliva, buccal scraping) | 850 | up to 3 | |
| 537 | Epstein-Barr virus, Real-Time PCR qualitative determination (blood plasma) | 1050 | up to 6 | |
| Other infections | ||||
| 945 | Borrelia IgG antibodies (Borrelia IgG) | 450 | 1 | |
| 946 | IgM antibodies to Borrelia (Borrelia IgM) | 450 | 1 | |
| 403 | Whooping cough (Bordetella pertussis), IgG antibodies | 690 | up to 3 | |
| 404 | Whooping cough (Bordetella pertussis), IgM antibodies | 690 | up to 3 | |
| SARS-CoV-2 coronavirus (COVID-19) | ||||
| 405 | SARS-CoV-2 coronavirus (COVID-19) IgG antibodies, ELISA | 500 | 1 | |
| 406 | SARS-CoV-2 coronavirus (COVID-19) IgM antibodies, ELISA | 500 | 1 | |
| 408 | Coronavirus SARS-CoV-2 (COVID-19), by PCR (only Lutsk, 2b Leonтовича St.) | 990 | 2-3 | |
| 2067 | Package No. 67 «Coronavirus, COVID-19, SARS-CoV-2 IgM+IgG, (ELISA method)» | 1000 | 1 | |
| 407 | Coronavirus (SARS-CoV-2), antigen | 350 | 1 | |
| PARASITIC TESTS | ||||
| 191 | Giardia, total antibodies | 510 | 1 | |
| 192 | Ascaris, total antibodies | 680 | 1 | |
| 160 | Toxocara, total antibodies | 550 | 1 | |
| 165 | Opisthorchis, total antibodies | 500 | 1-2 | |
| 166 | Echinococcus, total antibodies | 500 | 1-2 | |
| 167 | Trichinella, total antibodies | 500 | 1-2 | |
| 2032 | Package No. 32 «Parasitic-3» Trichinella, Opisthorchis, Toxocara, Echinococcus, total antibodies | 2000 | 1-2 | |
| 2064 | Package No. 64 «Parasitic-2» Giardia, Ascaris, Toxocara, total antibodies | 1500 | 1 | |
| 2025 | Package No. 25 «Extended Parasitic 1» stool for ova/parasites; Giardia microscopy (Parasep system), Ascaris total antibodies, Giardia total antibodies, Opisthorchis, Trichinella, Toxocara, Echinococcus total antibodies | 2900 | 1-2 | |
| ALLERGY DIAGNOSTICS | ||||
| 181 | Total immunoglobulin E (tlgE) | 360 | 1 | |
| 15 | Eosinophil cationic protein | 700 | 1 | |
| 182 | Inhalation panel: birch pollen, alder pollen, hazel pollen, oak pollen, timothy grass, rye pollen, wormwood pollen, plantain pollen, D.pteronossinus mite, D.farinae mite, dog epithelium, cat epithelium, horse epithelium, guinea pig epithelium, hamster epithelium, rabbit epithelium, fungus Asp. Fumigatus, fungus Cladosp. Herbarum, fungus Pen.Notatus, fungus Alternia Тenuis | 1600 | 1-2 | |
| 183 | Pediatric panel: soy, milk, chicken egg white, crab, shrimp (Atlantic and Pacific), peach, D.pteronossinus mite, D.farinae mite, cockroach, dog epithelium, cat epithelium, fungus Alternia tenuis, alder pollen, birch pollen, ragweed pollen, wormwood pollen, timothy grass pollen, rye pollen, house dust, total IgE.> | 1600 | 1-2 | |
| 184 | Pediatric differentiated panel: milk, casein, alpha-lactalbumin, beta-lactoglobulin, bovine serum albumin, egg white and yolk, rice, soy, banana, pork, veal, chicken, flour mix (wheat, rice, barley, oats), baker's yeast, D.pteronyssinus and D.farinae mites, Cladosporium herbarum and Alternatia alternata fungi, pollen mix (birch, oak), pollen mix (alder, hazel), grass mix (hedgehog grass, brome, meadow fescue, ryegrass, meadow timothy), total IgE | 1600 | 1-2 | |
| 185 | Food panel: hazelnut, peanut, walnut, almond, milk, chicken egg white, chicken egg yolk, casein, potato, celery, carrot, tomato, cod, shrimp, peach, apple, soy, wheat flour, sesame, rye flour | 1600 | 1-2 | |
| 188 | Milk+gluten panel: Milk, Alpha-lactalbumin, Beta-lactalbumin, Bovine serum albumin, Gluten, Casein | 1200 | 1-2 | |
| 189 | Multiplex allergy diagnostics ALEX2 (Total IgE + specific IgE to 295 allergens) | 5800 | up to 5 | |
| 190 | FOX (FOOD XPLORER) semi-quantitative test for determining Ig G-dependent hypersensitivity to 286 food products (Lutsk) | 5800 | up to 5 | |
| CELIAC DIAGNOSTICS | ||||
| 505 | Tissue transglutaminase, IgA/N antibodies | 2200 | up to 5 | |
| 506 | Tissue transglutaminase, IgG/N antibodies | 2200 | up to 5 | |
| BACTERIOLOGICAL TESTING | ||||
| 201 | Eye culture with antibiotic susceptibility testing | 600 | up to 7 | |
| 202 | Bacteriological culture from the throat with antibiogram | 600 | up to 7 | |
| 203 | Wound culture with antibiotic susceptibility testing | 600 | up to 7 | |
| 204 | Semen culture with antibiotic susceptibility testing | 600 | up to 7 | |
| 205 | Bacteriological culture of prostate secretion with antibiogram | 600 | up to 7 | |
| 206 | Bacteriological culture of milk with antibiogram | 600 | up to 7 | |
| 207 | Blood culture for sterility with antibiogram | 600 | up to 14 | |
| 208 | Bacterial culture of secretions from the genitourinary organs with antibiogram | 600 | up to 7 | |
| 209 | Nasal culture with antibiogram | 600 | up to 7 | |
| 210 | Stool culture for dysbiosis with antibiogram | 700 | up to 14 | |
| 211 | Urine culture with antibiotic susceptibility testing | 600 | up to 7 | |
| 212 | Sputum culture with antibiotic susceptibility testing | 600 | up to 7 | |
| 213 | Ear culture with antibiotic susceptibility testing | 600 | up to 7 | |
| 218 | Bacteriological examination of a vaginal-rectal smear for detection of Streptococcus agalactiae with antibiotic susceptibility testing | 700 | up to 7 | |
| 219 | Diphtheria test (BL) | 600 | up to 7 | |
| BIOCHEMICAL TESTS | ||||
| Clinical chemistry | ||||
| 220 | AST (aspartate aminotransferase) | 180 | 1 | |
| 221 | ALT (alanine aminotransferase) | 180 | 1 | |
| 222 | Total bilirubin | 180 | 1 | |
| 223 | Direct bilirubin | 180 | 1 | |
| 224 | GGT (gamma-glutamyl transpeptidase) | 180 | 1 | |
| 225 | Alkaline phosphatase | 180 | 1 | |
| 227 | Total protein | 180 | 1 | |
| 228 | Albumin | 180 | 1 | |
| 230 | Amylase | 180 | 1 | |
| 231 | Pancreatic amylase | 180 | 1 | |
| 232 | Lipase | 180 | 1 | |
| 239 | Urea | 180 | 1 | |
| 226 | Urea nitrogen | 220 | ||
| 240 | Creatinine | 180 | 1 | |
| 241 | Uric acid | 180 | 1 | |
| 245 | Calcium | 180 | 1 | |
| 246 | Magnesium | 180 | 1 | |
| 247 | Phosphorus | 180 | 1 | |
| 250 | Iron | 180 | 1 | |
| 972 | Transferrin saturation with iron | 750 | 3 | |
| 249 | Zinc | 500 | 1 | |
| 266 | Ionized calcium (Lutsk only) | 250 | 1 | |
| 242 | Potassium (Lutsk only) | 250 | 1 | |
| 243 | Sodium (Lutsk only) | 250 | 1 | |
| 2026 | Package No. 26 “Liver function tests” AST (aspartate aminotransferase), ALT (alanine aminotransferase), Fractionated bilirubin, GGT (gamma-glutamyl transpeptidase), Alkaline phosphatase, Albumin, Total protein | 1250 | 1 | |
| 2027 | Package No. 27 “Pancreas” Lipase, Amylase in blood and urine, Pancreatic amylase in blood and urine | 900 | 1 | |
| 2047 | Package No. 47 “Kidney function tests” Creatinine, Urea, Uric acid, Albumin, Calcium | 900 | 1 | |
| Urine biochemistry | ||||
| 258 | Urine amylase | 180 | 1 | |
| 0057 | Pancreatic amylase in urine | 180 | 1 | |
| Lipid metabolism markers | ||||
| 233 | Cholesterol | 180 | 1 | |
| 234 | Triglycerides | 180 | 1 | |
| 235 | HDL (high-density lipoproteins) | 180 | 1 | |
| 236 | HDL (low-density lipoproteins) | 180 | 1 | |
| 2028 | Package No. 28 "Lipoproteins fractionated" Cholesterol, Triglycerides, HDL (high-density lipoproteins), LDL (low-density lipoproteins), VLDL (very low-density lipoproteins), Atherogenic coefficient | 720 | 1 | |
| Carbohydrate metabolism markers | ||||
| 237 | Glucose | 180 | 1 | |
| 238 | Glycated hemoglobin (HbA1c) | 360 | 1 | |
| 267 | Glucose tolerance test | 500 | 1 | |
| 923 | C-peptide | 330 | 1 | |
| 924 | Insulin | 330 | 1 | |
| 304 | HOMA index (insulin + blood glucose) | 510 | 1 | |
| 2036 | Package No. 36 «Carbohydrate standard» Glucose, Glycated hemoglobin, C-peptide | 870 | 1 | |
| 2037 | Package No. 37 «Comprehensive carbohydrate» (glucose, glycated hemoglobin, C-peptide, insulin, HOMA index) | 1200 | 1 | |
| Cardiac markers | ||||
| 878 | Antibodies to cyclic citrullinated peptide (ACCP) | 750 | up to 5 | |
| 954 | Antibodies to mutated citrullinated vimentin IgG (Anti-MCV) | 2500 | up to 8 | |
| 961 | Homocysteine (Lutsk) | 650 | 1 | |
| Diagnosis of rheumatism | ||||
| 253 | C-reactive protein (CRP) - high-sensitivity, quantitative determination | 300 | 1 | |
| 254 | Rheumatoid factor (RF) | 150 | 1 | |
| 255 | Antistreptolysin O (ASLO) | 200 | 1 | |
| Phosphorus-calcium metabolism markers | ||||
| 888 | Vitamin D 3 (25- OH ) | 600 | 1-2 | |
| 889 | Parathyroid hormone (Lutsk) | 350 | up to 3 | |
| 2069 | Package No. 69 ''Phosphorus-calcium metabolism'' (phosphorus, ionized calcium, vitamin D 3 (25-OH), parathyroid hormone) | 1350 | 2 | |
| Antiphospholipid metabolism | ||||
| 301 | Antibodies to phospholipids IgG | 1500 | up to 8 | |
| 302 | Antibodies to phospholipids IgM | 1500 | up to 8 | |
| 950 | Lupus anticoagulant (screening) | 1500 | up to 7 | |
| 951 | Antibodies IgM to cardiolipin | 1500 | up to 8 | |
| 952 | Antibodies IgG to cardiolipin | 1500 | up to 8 | |
| ANEMIA DIAGNOSTICS | ||||
| 920 | Ferritin | 400 | 1 | |
| 921 | Vitamin B12 (cyanocobalamin) | 400 | 1-2 | |
| 922 | Folic acid (vitamin B9) | 400 | 1-2 | |
| 971 | Transferrin | 550 | up to 3 | |
| COAGULOGRAM | ||||
| 298 | Prothrombin index (INR) (collection only Lutsk) | 250 | 1 | |
| 299 | APTT (collection only Lutsk) | 200 | 1 | |
| 300 | Fibrinogen (sample collection only Lutsk) | 200 | 1 | |
| 960 | D-dimer | 325 | 1 | |
| BLOOD GROUP | ||||
| 268 | Blood group and Rh factor | 300 | 1 | |
| 295 | Anti-Rhesus antibodies | 400 | 1-2 | |
| GENERAL CLINICAL TESTS | ||||
| Blood test | ||||
| 272 | Complete blood count | 270 | 1 | |
| 273 | Reticulocytes | 200 | 1 | |
| Urine test | ||||
| 274 | General urinalysis | 200 | 1 | |
| 275 | Urinalysis according to Nechiporenko | 200 | 1 | |
| Cytological tests | ||||
| 277 | Cytomorphological examination | 300 | 1-2 | |
| 278 | Vaginal smear for flora | 300 | 1-2 | |
| 279 | Discharge from the genitourinary organs (urethra) | 300 | 1-2 | |
| 280 | Analysis of prostate secretion | 180 | 1-2 | |
| 555 | Liquid cytology Pap test | 820 | 5-7 | |
| 5540 | Liquid cytology Pap test + High-Risk HPV DNA test (HPV DNA of high oncogenic risk) | 1700 | 5-7 | |
| Rapid diagnostics | ||||
| 281 | Immunochromatographic testing for IgG and IgM antibodies to syphilis | 300 | 1 | |
| 283 | Immunochromatographic test for antibodies to hepatitis B virus (HBSAg) | 300 | 1 | |
| 284 | Immunochromatographic test for antibodies to hepatitis C virus | 300 | 1 | |
| 285 | Immunochromatographic test for antibodies to HIV 1/2 (HIV1/2)(Lutsk) | 300 | 1 | |
| 303 | Rapid test for diagnosis of multi-infections | 900 | 1 | |
| 401 | Test for detection of group A streptococcus | 290 | 1 | |
| 412 | SARS-CoV-2 antigen test + influenza A and influenza B | 500 | 1 | |
| 199 | Rotavirus + adenovirus, qualitative determination (antigen in stool) | 600 | 1 | |
| 402 | Procalcitonin test (PCT) | 350 | 1 | |
| Package offers | ||||
| 2060 | Package No. 60 ''Surgical'' | 2800 | 1 | |
| Other tests | ||||
| 286 | Coprogram | 300 | 1 | |
| 288 | Scraping for enterobiasis | 200 | 1 | |
| 290 | Stool test for occult blood | 250 | 1 | |
| 296 | Skin scraping for parasitic fungi | 250 | 1 | |
| 297 | Examination for demodicosis (face or eyelashes) | 250 | 1 | |
| 270 | Nazocytogram | 250 | 1 | |
| 503 | Fecal calprotectin (quantitative determination) | 1100 | up to 3 | |
| 504 | Fecal elastase | 1050 | up to 7 | |
| IMMUNITY TESTS | ||||
| 826 | Immunoglobulin A (IgA) | 500 | up to 5 | |
| 827 | Immunoglobulin G (IgG) | 300 | up to 5 | |
| 828 | Immunoglobulin M (IgG) | 300 | up to 5 | |
| PCR DIAGNOSTICS | ||||
| Urogenital infections | ||||
| 509 | Trichomonas (Trichomonasvaginalis), Real-Time PCR with quantitative determination if detected (urogenital scraping) | 580 | up to 3 | |
| 510 | Gardnerella (Gardnerella vaginalis), Real-Time PCR with quantitative determination if detected (urogenital scraping) | 640 | up to 3 | |
| 511 | Chlamydia (Chlamidiatrachomatis), Real-Time PCR with quantitative determination if detected (urogenital swab) | 640 | up to 3 | |
| 512 | Mycoplasma hominis (Mycoplasma hominis), Real-Time PCR with quantitative determination if detected (urogenital scraping) | 640 | up to 3 | |
| 513 | Mycoplasma genitalium (Mycoplasma genitalium), Real-Time PCR with quantitative determination if detected (urogenital scraping) | 640 | up to 3 | |
| 514 | Ureaplasma urealyticum (Ureaplasmaurealiticum) and Ureaplasma parvum (Ureaplasmaparvum), Real-Time PCR with quantitative determination if detected (urogenital scraping) | 650 | up to 3 | |
| 711 | Candida species identification (Candida albicans+crusei+glabrata), Real-Time PCR with quantitative determination if detected | 650 | up to 3 | |
| 516 | Gonorrhea (Neisseriagonorrhoeae), Real-Time PCR with quantitative determination if detected (urogenital scraping) | 570 | up to 3 | |
| 536 | Package No. 32 «PCR – 1» Chlamydia trachomatis, Ureaplasma parvum, Ureaplasma urealyticum, Mycoplasma genitalium Real-Time PCR with quantitative determination if detected (urogenital scraping) | 1900 | up to 3 | |
| 538 | Package No. 33 «PCR – 2» Chlamydia trachomatis, Ureaplasma parvum, Ureaplasma urealyticum Real-Time PCR with quantitative determination if detected (urogenital scraping) | 1250 | up to 3 | |
| Papillomavirus infections | ||||
| 521 | Human papillomavirus (HPV) genotyping 12 types (16,18, 31,33,35,39,45,51,52,56,58,59), Real-Time PCR quantitative determination for each type (urogenital scraping) | 950 | up to 3 | |
| 332 | Human papillomavirus (HPV) genotyping 15 types (16,18,31,33,35,39,45,51,52,53,56,58,59,66,68), quantitative PCR for each type (urogenital scraping) | 1100 | up to 3 | |
| 522 | Human papillomavirus (HPV) genotyping, type 23 (6,11,16,18,26,31,33,35,39,44,45,51,52,53,56,58,59,66,68,73,82), quantitative PCR for each type (urogenital swab) | 1500 | up to 5 | |
| Study of the urogenital tract biocenosis | ||||
| 524 | Urogenital biocenosis. Examination of the biocenosis of the urogenital tract. Total bacterial mass (quantitative), Lactobacillus spp. (quantitative), Gardnerella vaginalis/Prevotella bivia/Porphyromonas spp. (quantitative); Ureaplasma (urealyticum and parvum) (quantitative), Candida spp. (qualitative), Mycoplasma hominis (qualitative), Mycoplasma genitalium (qualitative), Trichomonas vaginalis (qualitative), Neisseria gonorrhoeae (qualitative), Chlamydia trachomatis (qualitative), Herpes simplex virus types 1 and 2 (qualitative), Cytomegalovirus (qualitative), Real-time PCR quantitative/qualit | 1990 | up to 3 | |
| TORCH infections | ||||
| 525 | Cytomegalovirus, Real-Time PCR with quantitative determination if detected (saliva, discharge, scraping) | 640 | up to 3 | |
| 526 | Toxoplasma, Real-Time PCR qualitative determination (scraping, blood plasma) (underline required) | 1050 | up to 5 | |
| 529 | Herpes simplex virus type 1 and 2 (HSV-1 and 2), qualitative PCR genotyping (scraping, discharge, blood plasma) (underline required) | 640 | up to 6 | |
| 530 | Varicella-Zoster virus (VZV), qualitative PCR (blood) | 990 | up to 6 | |
| Hepatitis | ||||
| 531 | Hepatitis B virus (HBV), Real-Time PCR qualitative determination | 1200 | up to 8 | |
| 532 | Hepatitis B virus (HBV), Real-Time PCR quantitative determination | 1700 | up to 5 | |
| 533 | Hepatitis C virus (HCV), qualitative Real-Time PCR | 1000 | up to 5 | |
| 534 | Hepatitis C virus (HCV), Real-Time PCR quantitative determination | 2000 | up to 5 | |
| 306 | Lactose metabolism genetics (buccal swab) | 600 | up to 3 | |
| 552 | Folate cycle, gene polymorphisms (MTHFR,MTR, MTRR) (PCR) | 2000 | up to 7 | |
| COLLECTION OF MATERIAL | ||||
| 91 | Blood collection from vein, finger | 70 | ||
| 92 | Collection of materials for bacteriological testing | 70 | ||
| 94 | Sample collection for COVID-19 PCR | 70 | ||
| 95 | Scraping for demodicosis and scraping for parasitic fungi | 70 | ||
| 96 | Collection of material from the urogenital tract (PCR) | 70 | ||
| Sample collection for liquid cytology | 70 | |||
| 97 | Sample collection from the urogenital tract (blood culture) | 70 | ||
| 90 | Freezing of material (storage period 1 month) | 40 | ||
| 02 | Sample collection using disposable systems | 50 | ||